Last10K.com

American Cryostem Corp (CRYO) SEC Filing 10-K Annual report for the fiscal year ending Friday, September 30, 2016

American Cryostem Corp

CIK: 1468679 Ticker: CRYO
Document and Entity Information - USD ($)
12 Months Ended
Sep. 30, 2016
Mar. 31, 2016
Jan. 10, 2016
Document and Entity Information:   
Entity Registrant NameAMERICAN CRYOSTEM Corp  
Document Type10-K  
Document Period End DateSep. 30, 2016  
Amendment Flagfalse  
Entity Central Index Key0001468679  
Current Fiscal Year End Date--09-30  
Entity Common Stock, Shares Outstanding  37,553,905
Entity Public Float $ 12,481,598 
Entity Filer CategorySmaller Reporting Company  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Well-known Seasoned IssuerNo  
Document Fiscal Year Focus2016  
Document Fiscal Period FocusFY  

View differences made from one year to another to evaluate American Cryostem Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Cryostem Corp.

Continue

Assess how American Cryostem Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Cryostem Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
6. Debt - Summary Of Debt Outstanding (details)
9. Option Issuances - Summary Of Common Stock Options Outstanding (details) {stockholders'equity}
Balance Sheets
Balance Sheets (parenthetical)
Statements Of Cash Flows
Statements Of Changes In Shareholder's Equity
Statements Of Operations
1. Organization Of The Company And Significant Accounting Policies
1. Organization Of The Company And Significant Accounting Policies (policies)
1. Organization Of The Company And Significant Accounting Policies (tables)
1. Organization Of The Company And Significant Accounting Policies - Summary Of Estimated Useful Life (detail Textuals)
1. Organization Of The Company And Significant Accounting Policies - Summary Of Estimated Useful Life (details)
1. Organization Of The Company And Significant Accounting Policies - Summary Of Inventory (details)
10. Fair Values Of Financial Instruments
11. Commitment And Contingencies
11. Commitments & Contingencies (details)
11. Commitments & Contingencies (tables)
12. Concentrations Of Credit
13. Joint Venture
13. Joint Venture (detail Textuals)
14. Related Party Transactions
14. Related Party Transactions (detail Textuals)
15. Subsequent Events
2. Going Concern
3. Loss Per Share
3. Loss Per Share (tables)
3. Loss Per Share - Summary Of Net Loss Per Share (details)
4. Fixed Assets
4. Fixed Assets (detail Textuals)
4. Fixed Assets (tables)
4. Fixed Assets - Summary Of Fixed Assets (details)
5. Patent & Patents Filings
6. Debt
6. Debt (tables)
7. Administration Expense
7. Administration Expense (tables)
7. Administration Expense - Summary Of Administrative Expenses (details)
8. Common Stock Issuances
8. Common Stock Issuances (detail Textuals)
9. Option Issuances
9. Option Issuances (detail Textuals)
9. Option Issuances (tables)

Material Contracts, Statements, Certifications & more

American Cryostem Corp provided additional information to their SEC Filing as exhibits

Ticker: CRYO
CIK: 1468679
Form Type: 10-K Annual Report
Accession Number: 0001019056-17-000033
Submitted to the SEC: Fri Jan 13 2017 4:08:42 PM EST
Accepted by the SEC: Fri Jan 13 2017
Period: Friday, September 30, 2016
Industry: Health And Allied

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cryo/0001019056-17-000033.htm